Mankind Pharma Limited — Call Transcript 2024

Nov 5, 2024

==> picture [559 x 53] intentionally omitted <==

==> picture [559 x 55] intentionally omitted <==

Date: November 5, 2024

BSE Limited

P J Towers, Dalal Street, Mumbai – 400 001

Script Code: 543904

National Stock Exchange of India Limited Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Bandra (E), Mumbai – 400 051

Symbol: MANKIND

Dear Sir/ Madam,

Subject: Investor Conference Call for Q2 & H1 FY25 – Audio Recording

Pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to our intimation dated October 25, 2024 under subject ‘Intimation of Investor Conference Call for Q2 & H1 FY25 with Senior Management of Mankind Pharma Limited (“the Company”)’ , the audio recording of the Call held today i.e. November 5, 2024 is available on the website of the Company at: https://www.mankindpharma.com/media/investor/q2fy25-earnings-call-recording1730816478.mp3

You are requested to kindly take the same on records.

Thanking You,

Yours Faithfully,

For Mankind Pharma Limited

PRADEEP Digitally signed by PRADEEP CHUGH CHUGH Date: 2024.11.05 21:33:10 +05'30' Pradeep Chugh Company Secretary and Compliance Officer

==> picture [557 x 60] intentionally omitted <==